Wells Fargo & Company Esperion Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 108,401 shares of ESPR stock, worth $108,401. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,401
Previous 106,379 1.9%
Holding current value
$108,401
Previous $175,000 36.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$1.61 - $3.83 $3,255 - $7,744
2,022 Added 1.9%
108,401 $238,000
Q3 2024

Nov 13, 2024
BUY
$1.61 - $2.73 $508 - $862
316 Added 0.3%
106,379 $175,000
Q2 2024

Aug 13, 2024
BUY
$1.84 - $3.24 $143,991 - $253,549
78,256 Added 281.43%
106,063 $235,000
Q1 2024

May 10, 2024
BUY
$2.02 - $3.02 $49,421 - $73,887
24,466 Added 732.3%
27,807 $74,000
Q4 2023

Feb 09, 2024
BUY
$0.73 - $3.08 $62 - $264
86 Added 2.64%
3,341 $9,000
Q3 2023

Nov 13, 2023
BUY
$0.96 - $1.79 $98 - $184
103 Added 3.27%
3,255 $3,000
Q2 2023

Aug 15, 2023
SELL
$1.2 - $1.76 $18,704 - $27,433
-15,587 Reduced 83.18%
3,152 $4,000
Q1 2023

May 12, 2023
BUY
$1.46 - $7.3 $19,701 - $98,506
13,494 Added 257.27%
18,739 $29,000
Q4 2022

Feb 13, 2023
SELL
$5.09 - $8.5 $488 - $816
-96 Reduced 1.8%
5,245 $32,000
Q3 2022

Nov 14, 2022
SELL
$5.45 - $8.13 $6,398 - $9,544
-1,174 Reduced 18.02%
5,341 $36,000
Q2 2022

Aug 12, 2022
SELL
$4.77 - $6.67 $20,692 - $28,934
-4,338 Reduced 39.97%
6,515 $41,000
Q1 2022

May 16, 2022
SELL
$3.34 - $5.56 $13,049 - $21,722
-3,907 Reduced 26.47%
10,853 $50,000
Q4 2021

Feb 14, 2022
BUY
$4.81 - $11.92 $58,340 - $144,577
12,129 Added 461.0%
14,760 $74,000
Q3 2021

Nov 15, 2021
SELL
$11.34 - $21.37 $276,231 - $520,551
-24,359 Reduced 90.25%
2,631 $31,000
Q2 2021

Aug 16, 2021
BUY
$19.4 - $28.71 $322,893 - $477,849
16,644 Added 160.87%
26,990 $572,000
Q1 2021

May 13, 2021
SELL
$25.12 - $36.89 $1.25 Million - $1.83 Million
-49,644 Reduced 82.75%
10,346 $290,000
Q4 2020

Feb 09, 2021
SELL
$24.2 - $35.76 $89,370 - $132,061
-3,693 Reduced 5.8%
59,990 $1.56 Million
Q3 2020

Nov 05, 2020
SELL
$31.18 - $52.71 $361,469 - $611,067
-11,593 Reduced 15.4%
63,683 $2.37 Million
Q2 2020

Aug 13, 2020
BUY
$30.04 - $51.31 $1.53 Million - $2.62 Million
51,076 Added 211.06%
75,276 $3.86 Million
Q1 2020

May 14, 2020
BUY
$27.44 - $73.84 $664,048 - $1.79 Million
24,200 New
24,200 $762,000

Others Institutions Holding ESPR

# of Institutions
212
Shares Held
128M
Call Options Held
1.78M
Put Options Held
1.27M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $66.6M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email